LBA59 Associations of ctDNA clearance and pathological response with neoadjuvant treatment in patients with resectable NSCLC from the phase III AEGEAN trial

M. Reck, D. Gale, D. Harpole,J.M. Taube,T. Mitsudomi, M.J. Hochmair, T. Winder, Z. Zhu, Z. Lai,R. Stewart, D.R. Hodgson, G.J. Doherty,J.V. Heymach

Annals of Oncology(2023)

引用 0|浏览0
暂无评分
关键词
ctdna clearance,neoadjuvant treatment,resectable nsclc
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要